Shenzhen Chipscreen Biosciences Hits Day Low Amid Price Pressure at CNY 23.92

Shenzhen Chipscreen Biosciences Co., Ltd. experienced a notable decline today, with the stock dropping by 4.97% and reaching an intraday low of CNY 23.92. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.7% on the same day. Over the past week, Shenzhen Chipscreen has seen a more significant downturn, with a 10.7% decrease, while its one-month performance reflects a substantial drop of 22.43%. Year-to-date, the stock has declined by 16.91%, despite a positive annual return of 6.03% over the last year, which outpaces the China Shanghai Composite's 16.95% gain. The company's financial metrics indicate a challenging environment, with a return on equity of 3.77% and a price-to-earnings ratio of 102.00. Additionally, the company has reported a negative net worth and low management efficiency, as evidenced by a return on capital employed of 0%. Despite these challenges, Shenzhen Chipscreen has shown some resilience, with a significant increase in pre-tax profit and net profit in recent quarters.